SS&C Technologies Holdings Inc
SSNC Nasdaq Services-Prepackaged Software Financials FY2016βFY2025
What SS&C Technologies Holdings Inc does
No business description yet.
- Legal name
- SS&C Technologies Holdings Inc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001193125-26-076745
0001402436
Revenue and margins
SS&C Technologies Holdings Inc had $6.3B of revenue in fiscal 2025, up 6.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 19.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.7B in fiscal 2025, 26.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
SS&C Technologies Holdings Inc returned $1.3B to shareholders in fiscal 2025, 78% of free cash flow. The diluted share count fell 0.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably SS&C Technologies Holdings Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $564M | $440M | $432M | $567M | $462M |
| Debt incl. finance leases | $5.9B | $7.1B | $6.7B | $7.0B | $7.4B |
| Net debt / EBITDA | 2.8x | 3.7x | 3.3x | 3.2x | 3.3x |
| Debt / equity | 1.0x | 1.2x | 1.1x | 1.1x | 1.1x |
| Interest coverage | 6.0x | 3.7x | 2.5x | 2.9x | 3.3x |
| Current ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Total assets | $17.3B | $16.7B | $18.1B | $19.0B | $20.7B |
| Total liabilities | $11.1B | $10.6B | $11.7B | $12.4B | $13.8B |
| Shareholders' equity | $6.2B | $6.0B | $6.3B | $6.5B | $6.9B |
| Net debt (β = net cash) | $5.4B | $6.6B | $6.3B | $6.4B | $7.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 8 / 9 | 4 / 9 | 7 / 9 | 8 / 9 | 7 / 9 | 6 / 9 | 6 / 9 | 9 / 9 | 5 / 9 |
| Accruals ratio | β5.0% | β2.5% | β5.0% | β5.4% | β3.4% | β3.8% | β2.8% | β3.5% | β3.4% | β4.8% |
| Altman Z'' | 1.14 | 1.82 | 0.82 | 1.06 | 1.35 | 1.65 | 1.69 | 1.68 | 1.82 | 1.77 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.5B | $1.7B | $3.4B | $4.6B | $4.7B | $5.1B | $5.3B | $5.5B | $5.9B | $6.3B |
| Net interest income | β$128M | β$107M | β | β | β | β | β | β | β | β |
| Gross profit | $681M | $789M | $1.4B | $2.0B | $2.1B | $2.4B | $2.5B | $2.7B | $2.9B | $3.0B |
| Research and development | $153M | $153M | $318M | $384M | $399M | $415M | $447M | $474M | $518M | $508M |
| Operating income | $289M | $397M | $429M | $914M | $986M | $1.2B | $1.1B | $1.2B | $1.3B | $1.4B |
| Interest expense | $130M | $109M | $280M | $410M | $250M | $206M | $312M | $476M | $463M | $435M |
| Pretax income | $164M | $283M | $125M | $532M | $776M | $1.0B | $876M | $858M | $894M | $975M |
| Income tax | $32.6M | β$46.2M | $21.9M | $93.2M | $151M | $236M | $227M | $249M | $132M | $176M |
| Net income | $131M | $329M | $103M | $439M | $625M | $800M | $650M | $607M | $761M | $797M |
| Diluted EPS | $0.64 | $1.55 | $0.42 | $1.66 | $2.35 | $2.99 | $2.48 | $2.39 | $3.00 | $3.15 |
| Diluted shares | 0.21B | 0.21B | 0.24B | 0.26B | 0.27B | 0.27B | 0.26B | 0.25B | 0.25B | 0.25B |
| Cash flow | ||||||||||
| Cash from operations | $418M | $472M | $640M | $1.3B | $1.2B | $1.4B | $1.1B | $1.2B | $1.4B | $1.7B |
| Capital expenditure | $27.9M | $35.5M | $33.6M | $63.0M | $34.8M | $51.3M | $63.4M | $56.6M | $61.4M | $80.8M |
| Free cash flow | $391M | $436M | $607M | $1.3B | $1.1B | $1.4B | $1.1B | $1.2B | $1.3B | $1.7B |
| Depreciation and amortization | $229M | $237M | $519M | $775M | $725M | $667M | $672M | $670M | $680M | $704M |
| Stock-based compensation | $50.5M | $41.5M | $96.9M | $72.4M | $87.8M | $114M | $125M | $160M | $203M | $258M |
| Acquisitions | $458M | $17.4M | $7.1B | $94.1M | $116M | β$7.3M | $1.6B | $34.1M | $647M | $1.1B |
| Share buybacks | $0.0M | β | β | $60.3M | $228M | $488M | $476M | $472M | $738M | $1.0B |
| Dividends paid | $50.1M | $54.4M | $70.9M | $108M | $136M | $174M | $203M | $221M | $245M | $254M |
| Dividends and buybacks | $50.1M | $54.4M | $70.9M | $168M | $364M | $662M | $679M | $693M | $982M | $1.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $118M | $64.1M | $167M | $153M | $209M | $564M | $440M | $432M | $567M | $462M |
| Total debt | $2.5B | $2.0B | $8.3B | $7.2B | $6.4B | $5.9B | $7.1B | $6.7B | $7.0B | $7.4B |
| Current assets | $415M | $359M | $2.0B | $2.8B | $2.3B | $4.3B | $2.4B | $4.1B | $4.9B | $5.5B |
| Current liabilities | $561M | $444M | $1.9B | $2.8B | $2.3B | $3.9B | $2.2B | $3.8B | $4.4B | $5.1B |
| Property and equipment, net | $80.4M | $101M | $553M | $466M | $413M | $382M | $344M | $315M | $300M | $290M |
| Goodwill | $3.7B | $3.7B | $7.9B | $8.0B | $8.1B | $8.0B | $8.9B | $9.0B | $9.2B | $10.0B |
| Intangible assets | $1.5B | $1.3B | $5.0B | $4.4B | $3.9B | $3.4B | $3.7B | $3.3B | $3.1B | $3.2B |
| Total assets | $5.7B | $5.5B | $16.1B | $16.7B | $15.9B | $17.3B | $16.7B | $18.1B | $19.0B | $20.7B |
| Total liabilities | $3.4B | $2.9B | $11.5B | $11.6B | $10.2B | $11.1B | $10.6B | $11.7B | $12.4B | $13.8B |
| Preferred stock | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.3B | $2.7B | $4.6B | $5.1B | $5.7B | $6.2B | $6.0B | $6.3B | $6.5B | $6.9B |
| Margins | ||||||||||
| Gross margin | 46.0% | 47.1% | 40.0% | 43.6% | 44.9% | 47.7% | 47.6% | 48.2% | 48.7% | 48.2% |
| Operating margin | 19.5% | 23.7% | 12.5% | 19.7% | 21.1% | 24.6% | 21.6% | 22.0% | 22.8% | 22.9% |
| EBITDA margin | 34.9% | 37.9% | 27.7% | 36.5% | 36.7% | 37.8% | 34.3% | 34.2% | 34.4% | 34.1% |
| Net margin | 8.8% | 19.6% | 3.0% | 9.5% | 13.4% | 15.8% | 12.3% | 11.0% | 12.9% | 12.7% |
| FCF margin | 26.4% | 26.0% | 17.7% | 27.3% | 24.6% | 27.3% | 20.3% | 21.1% | 22.6% | 26.5% |
| Net interest share of revenue | β8.7% | β6.4% | β | β | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | 5.0% | 8.5% | 2.8% | 6.2% | 6.6% | 8.3% | 6.7% | 6.8% | 8.8% | 8.5% |
| Return on capital employed | 5.6% | 7.8% | 3.0% | 6.5% | 7.2% | 9.2% | 7.9% | 8.4% | 9.1% | 9.2% |
| Return on equity | 5.8% | 13.3% | 2.8% | 9.0% | 11.5% | 13.5% | 10.7% | 9.8% | 11.8% | 11.9% |
| Return on assets | 2.3% | 5.8% | 1.0% | 2.7% | 3.8% | 4.8% | 3.8% | 3.5% | 4.1% | 4.0% |
| Growth | ||||||||||
| Revenue growth | β | 13.1% | 104.2% | 35.4% | 0.8% | 8.2% | 4.6% | 4.2% | 6.9% | 6.6% |
| Net income growth | β | 151.1% | β68.6% | 324.9% | 42.6% | 28.0% | β18.7% | β6.6% | 25.3% | 4.8% |
| EPS growth | β | 142.2% | β72.9% | 295.2% | 41.6% | 27.2% | β17.1% | β3.6% | 25.5% | 5.0% |
| FCF growth | β | 11.7% | 39.0% | 108.6% | β9.1% | 19.8% | β22.3% | 8.2% | 14.6% | 25.4% |
| Share count change | β | 2.8% | 15.2% | 8.4% | 0.9% | 0.3% | β2.0% | β2.9% | β0.3% | β0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.6x | 3.1x | 8.5x | 4.1x | 3.6x | 2.8x | 3.7x | 3.3x | 3.2x | 3.3x |
| Debt / equity | 1.1x | 0.8x | 1.8x | 1.4x | 1.1x | 1.0x | 1.2x | 1.1x | 1.1x | 1.1x |
| Interest coverage | 2.2x | 3.7x | 1.5x | 2.2x | 3.9x | 6.0x | 3.7x | 2.5x | 2.9x | 3.3x |
| Current ratio | 0.7x | 0.8x | 1.1x | 1.0x | 1.0x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 0.7x | 0.8x | 1.1x | 1.0x | 1.0x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.9% | 2.1% | 1.0% | 1.4% | 0.7% | 1.0% | 1.2% | 1.0% | 1.0% | 1.3% |
| Stock comp / revenue | 3.4% | 2.5% | 2.8% | 1.6% | 1.9% | 2.3% | 2.4% | 2.9% | 3.5% | 4.1% |
| Payouts / FCF | 12.8% | 12.5% | 11.7% | 13.3% | 31.6% | 48.0% | 63.4% | 59.8% | 74.0% | 77.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 8.0 | 4.0 | 7.0 | 8.0 | 7.0 | 6.0 | 6.0 | 9.0 | 5.0 |
| Altman Z'' | 1.1 | 1.8 | 0.8 | 1.1 | 1.4 | 1.6 | 1.7 | 1.7 | 1.8 | 1.8 |
| Accruals ratio | β5.0% | β2.5% | β5.0% | β5.4% | β3.4% | β3.8% | β2.8% | β3.5% | β3.4% | β4.8% |
Source: SEC EDGAR XBRL filings (CIK 0001402436). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.